BioCentury
ARTICLE | Distillery Therapeutics

Cancer

May 1, 2018 11:29 PM UTC

Cell culture and mouse studies identified a TF-binding immunoconjugate that could help treat triple-negative breast cancer (TNBC). The immunoconjugate consists of a factor VII peptide light chain fuse...